BRIEF published on 07/06/2026 at 22:10, 3 months 4 days ago Abivax Secures $920 Million in Public Offering Biotechnology Abivax Ulcerative Colitis Public Offering American Depositary Shares
PRESS RELEASE published on 07/06/2026 at 22:05, 3 months 4 days ago Abivax Announces Closing of $920 Million Public Offering Abivax closes $920 million public offering, strengthening financial position. Proceeds to support operations until Q4 2029. Leerink Partners, Morgan Stanley, Piper Sandler, Guggenheim Securities involved in the offering Financial Position Abivax Morgan Stanley Public Offering Leerink Partners
BRIEF published on 07/02/2026 at 08:05, 3 months 9 days ago Abivax successfully concludes an ADS offer Biotechnology Abivax Offer Ads Investments
BRIEF published on 07/02/2026 at 08:05, 3 months 9 days ago Abivax's Offering Yields $920M Following Over-Allotment Exercise Biotechnology Abivax Obefazimod Capital Increase ADS Offering
PRESS RELEASE published on 07/02/2026 at 08:00, 3 months 9 days ago Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M) Abivax announces full exercise of underwriters' option to purchase additional ADSs, bringing gross proceeds of offering to $920M (€807M) Biotechnology Abivax Capital Increase Underwriters ADSs
BRIEF published on 07/01/2026 at 15:17, 3 months 9 days ago Abivax resumes trading of its shares on Euronext Paris Euronext Paris Biotechnology Actions Abivax Suspension
BRIEF published on 07/01/2026 at 15:17, 3 months 9 days ago Abivax relaunches trading of its shares on Euronext Paris Euronext Paris Ordinary Shares Abivax Inflammatory Diseases American Depositary Shares
BRIEF published on 07/01/2026 at 14:59, 3 months 9 days ago Abivax Resumes Trading on Euronext Paris Euronext Paris Biotechnology Abivax Ulcerative Colitis American Depositary Shares
PRESS RELEASE published on 07/01/2026 at 14:54, 3 months 9 days ago Abivax announces trading resumption of its ordinary shares on Euronext Paris Abivax announces resumption of trading for its ordinary shares on Euronext Paris following a public offering in the United States Euronext Paris Abivax Public Offering Phase 3 Clinical Trials Trading Resumption
BRIEF published on 07/01/2026 at 14:44, 3 months 9 days ago Abivax finalizes an oversubscribed $800 million ADS public offering Abivax Obefazimod Subscription Public Offering Ads
Published on 10/10/2026 at 04:45, 1 day 6 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 1 day 9 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 1 day 9 hours ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 1 day 12 hours ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 1 day 13 hours ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/10/2026 at 16:35, 19 hours 4 minutes ago New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 19 hours 9 minutes ago ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 1 day 1 hour ago ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 1 day 14 hours ago Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 1 day 14 hours ago EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Published on 10/09/2026 at 19:27, 1 day 16 hours ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/08/2026 at 18:30, 2 days 17 hours ago Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 2 days 17 hours ago Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 2 days 17 hours ago Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain
